- Zoomlion’s net income for the first half of 2025 increased by 21% compared to the previous year, reaching 2.76 billion yuan.
- Revenue for the same period saw a modest growth of 1.3%, totaling 24.85 billion yuan.
- Earnings per share (EPS) rose to 32 RMB cents, up from 27 RMB cents the previous year.
- The company declared an interim dividend of 20 RMB cents per share.
- Market analysts have issued 9 buy recommendations, 4 hold recommendations, and no sell recommendations for Zoomlion’s stock.
A look at Zoomlion Heavy Industry S A Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 5 | |
| Dividend | 5 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 2 | |
| OVERALL SMART SCORE | 3.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
“`html
Zoomlion Heavy Industry Science and Technology Co., Ltd. is a company that specializes in manufacturing and selling construction machinery, including concrete machinery, cranes, road machinery, and drilling equipment. They also produce other heavy construction equipment, environmental machinery, and satellite navigation products. Based on the Smartkarma Smart Scores, Zoomlion has received strong ratings across multiple factors. With a top-notch score of 5 for both Value and Dividend, it indicates that the company is perceived positively in terms of its stock value and dividend payouts. Additionally, a Growth score of 4 signifies promising potential for expansion. While Resilience and Momentum scores of 3 and 2, respectively, suggest a moderate level of stability amidst challenges and a slower pace of market trend adoption.
“`
Ultimately, based on the given Smart Scores, Zoomlion Heavy Industry S A seems to be a solid contender in the construction machinery sector, showing strength in value, dividend payouts, and growth potential amidst moderate resilience and momentum in the market.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
